Medical Technology Inc. Canada launches MED-JETŪ products in Russia after receiving regulatory approval.
Thursday, April 7th 2011
DENVER, CO, April 7 /PRNewswire/ - Medical International Technology Inc. (OTCBB:MDLH.ob - News) www.mitneedlefree.com is pleased to announce its latest achievements in Russia.
Over the past few months, MIT has been working closely with a Russian distributor to cover its marketing and sales in Russia. The newly signed distributor agreement and initial order worth approximately half-a-million dollars in Med-Jet products for the mesotherapy market is in progress.
Mr Karim Menassa was in Moscow for a sales and marketing kick off meeting to launch the Med-Jet products into the lucrative cosmetic market. The meeting was organized by MIT's Russian distributor and held at a prestigious Moscow hotel in the presence of over 300 specialists, in addition to Canadian dignitaries and local and international media.
MIT is delighted to have received the official certification to sell MED-JET® products to a very important market, said MIT President and CEO, Mr Karim Menassa. This new distributor will help MIT Canada achieve its business plan, which forecasts multi-million dollars of sales in different niche markets worldwide within the next 3 to 5 years.
Dr. Francis Bellido, Vice-President and Chief Strategy Officer of MIT Canada believes that the access to the fast growing Russian cosmetic market is a tremendous achievement and will serve to open future markets around the world to MIT's unique and effective products and technologies.
Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet® and Agro-Jet® needle-free injection system.